Stock Track | B&K CORP-B Plummets 8.38% in Intraday Trading on Weak Hong Kong Debut

Stock Track
12/22

B&K CORP-B (02396) saw its shares plummet by 8.38% during intraday trading on Monday, following a disappointing debut on the Hong Kong Stock Exchange.

The stock opened at HK$33.8 per share, significantly below its offer price of HK$38.2, reflecting investor skepticism or lack of confidence in the company's valuation. This weak debut led to a sharp decline in the stock's price during early trading.

B&K CORP-B is a China-based biopharmaceutical company specializing in protein-based therapies, particularly PDGF drugs for wound healing. The company raised approximately HK$600 million in net proceeds from its IPO, but the early drop in share price suggests challenges in gaining market traction.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10